Stay updated on Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Sign up to get notified when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    UI/layout adjustments and a timestamp update are visible on the study page. No substantive data such as eligibility criteria, endpoints, enrollment, or site information appears to have changed.
    Difference
    0.0%
    Check dated 2026-04-02T14:58:25.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.3 to v3.5.0, a UI/metadata update that does not alter the study information.
    Difference
    0.0%
    Check dated 2026-03-18T22:53:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision was updated from v3.4.2 to v3.4.3, indicating a minor maintenance update.
    Difference
    0.0%
    Check dated 2026-03-11T18:48:47.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2. Removed the government-funding notice and the prior Revision: v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-11T11:11:20.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding and NIH operations is added, and the page will now show revision: v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:32:58.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The changes are minor UI and metadata updates: a new glossary display option, capitalization adjustments for QC-related labels, and the addition of a Revision: v3.4.0 line, replacing previous versions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:38:59.000Z thumbnail image

Stay in the know with updates to Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Denosumab+Nivolumab in Stage IV NSCLC Clinical Trial page.